Related Experiment Video
Updated: Apr 4, 2026

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.9K
Comorbidity burden at dialysis initiation and mortality: A cohort study
Alwyn T Gomez1, Bryce A Kiberd2, J Patrick Royston3
1Faculty of Medicine, Dalhousie University, Halifax, NS Canada.
Canadian Journal of Kidney Health and Disease
|September 10, 2015
Summary
Comorbidity indices like the Charlson Comorbidity Index (CCI) and End-Stage Renal Disease Comorbidity Index (ESRD-CI) have limited ability to predict mortality risk in new dialysis patients. Further research is needed to assess their utility in current dialysis populations.
Area of Science:
- Nephrology
- Epidemiology
- Biostatistics
Background:
- High comorbidity at dialysis initiation correlates with increased mortality risk.
- Contemporary validation of comorbidity indices in dialysis patients is lacking.
Purpose of the Study:
- To evaluate the validity of the Charlson Comorbidity Index (CCI) and End-Stage Renal Disease Comorbidity Index (ESRD-CI).
- To determine the association between high comorbidity and mortality in incident dialysis patients.
Main Methods:
- A cohort study of 771 incident chronic dialysis patients from 2006-2013.
- Utilized patient charts and electronic records to classify comorbidities using CCI and ESRD-CI.
- Employed adjusted Cox proportional hazard models and Harrell's c-index to assess mortality risk and discrimination.
Main Results:
- Both CCI and ESRD-CI showed limited discrimination for death (c-indices 0.61 and 0.63, respectively).
- Higher ESRD-CI scores (≥4) were associated with a ~2-fold increased adjusted mortality risk.
- Higher CCI scores (≥4) were associated with a ~1.86- to 2.71-fold increased adjusted mortality risk.
Conclusions:
- The CCI and ESRD-CI demonstrate limited prognostic value for mortality in incident dialysis patients.
- The findings highlight the need to re-evaluate the utility of established comorbidity indices in contemporary dialysis cohorts.

